Ambu (Buy, TP: DKK270.00) - Visualisation set to be in focus
Ambu is due to report its Q4 results at 08:00 CET on 13 November. Having already unveiled its 2018/19 guidance at its CMD in October, focus is likely to be on continued momentum in the Visualisation business. On our view of still-strong conversion in pulmonary, we expect Ambu to reach its FY guidance. Any comments on its GI portfolio are also likely to be in focus, and possibly a topic on the conference call. We reiterate our BUY and DKK270 target price
DNB Markets is the investment banking arm of DNB Bank ASA and is focused primarily on the Nordic region, as well as internationally on niches such as global shipping, energy and related services, and seafood. DNB Markets offers services in FICC, Equities and Investment Banking advisory from offices in Oslo, Stockholm, London, Singapore and New York. Equity research coverage is offered on c250 Nordic companies. DNB was ranked no.2 in Extel Nordic Research 2017. The DNB Markets’ Credit and FICC Macro & FX Research teams are repeatedly highly rated by Prospera Nordic Institutional Investor Surveys.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.